|
BioNTech COVID vaccine faces 1st German lawsuit over side effects
Germany
1yr
|
|
|
Moderna says bivalent Covid vaccine approved for Hong Kong use
1yr
|
|
|
In Rwanda, mobile laboratories of Messenger RNA vaccines deployed by Biontech
Rwanda
1yr
|
|
|
Pfizer's bivalent COVID shot may be linked to stroke risk
US
Germany
1yr
|
|
|
UK signs deal with BioNTech for cutting-edge cancer trials
UK
1yr
|
|
|
|
BioNTech begins early human trials of mRNA-based Malaria vaccine
Germany
2yrs
|
|
|
Pfizer/BioNTech seek FDA authorization of updated Covid-19 vaccine for children under 5
2yrs
|
|
|
German expats in China will have access to BioNTech vaccine, says Scholz
China
Germany
2yrs
|
|
|
|
Fact Check-Preventing transmission never required for COVID vaccines’ initial approval; Pfizer...
2yrs
|
|
|
|
Team behind Pfizer-BioNTech COVID shot insist pandemic ISN'T over
Germany
2yrs
|
|
|
|
Hong Kong reviews proposal to give children mix of BioNTech and Sinovac jabs
2yrs
|
|
|
Moderna sues Pfizer/BioNTech for patent infringement over Covid vaccine
Germany
2yrs
|
|
|
Moderna suing Pfizer over Covid vaccine technology
Germany
2yrs
|
|
|
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine
US
Germany
2yrs
|
|
|
BioNTech breaks ground on first mRNA vaccine plant in Africa
Germany
Rwanda
2yrs
|
|
|
|
BioNTech to soon start mRNA vaccine factory construction in Rwanda
Rwanda
2yrs
|
|
|
|
BioNTech profits jump to $11.5B in 2021, up from $17M in 2020
Germany
2yrs
|
|
|
Germany’s BioNTech plans modular vaccine factories in Africa
Germany
Rwanda
Senegal
2yrs
|
|
|
BioNTech plans modular vaccine factories in Africa
Germany
2yrs
|
|
| |
|
Subscribe to our newsletter to receive today's important international stories in your inbox.
|
| |
|
|
Pfizer seeks authorization from US to vaccinate children under 5
US
2yrs
|
|
|
Pfizer-BioNTech seek authorization for Covid-19 vaccine for children under 5
US
2yrs
|
|
|
Pfizer seeks FDA approval to vaccinate 6-month-old infants
2yrs
|
|
|
From February BionTech vaccine for US infants
US
2yrs
|
|
|
|
Should you wait for an Omicron-specific booster? An expert weighs in
US
2yrs
|
|
|
|
Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine
2yrs
|
|
|
|
Pfizer and BioNTech team up to develop mRNA-based shingles vaccine - Financial Times
2yrs
|
|
|
|
Pfizer, BioNTech partner up again to develop mRNA shingles vaccine
US
Germany
2yrs
|
|
|
Mainz Celebrates Biontech's success, billionaire revised vaccine for the city
Germany
3yrs
|
|
|
BioNTech mRNA Cancer Vaccine Recruits First Patient Into Phase 2 Trials
US
3yrs
|
|
|
|
EU to place order with Pfizer for COVID shots adapted to Omicron
3yrs
|
|
|
coronavirus-covid19-canada-world-dec17-2021
3yrs
|
|
|
|
Booster jabs cut Omicron risk, data shows, as vaccine firm 'ready to shoot'
3yrs
|
|
|
BioNTech Founder Şahin on the Omicron Variant: “It Will Make Scientific Sense To Offer Booster...
3yrs
|
|
|
|
Booster needed for protection against omikron variant
3yrs
|
|
|
|
Omicron may alter COVID-19 pandemic's course, WHO's Tedros says
US
Germany
3yrs
|
|
|
|
Studies suggest Pfizer shot may protect only partially against Omicron
South Africa
3yrs
|
|
|
|
In Greece third dose for all after three months. In South Africa quadruple cases of OmoCron var...
South Africa
Greece
3yrs
|
|
|
|
BioNTech CEO confident of quickly adapting vaccine for Omicron
Germany
3yrs
|
|
|
BioNTech CEO confident of quickly adapting vaccine for Omicron
3yrs
|
|
|
|
BioNTech CEO confident of quickly adapting vaccine for Omicron
3yrs
|
|
|
‘Don’t freak out’ over omicron, says chief of covid vaccine maker BioNTech
3yrs
|
|
|
BioNTech CEO says vaccine likely to protect against severe COVID from Omicron
3yrs
|
|
|
|
BioNTech should protect from severe COVID-19 from omicron variant
3yrs
|
|
|
|
BioNTech works on its answer to new Covid variant
Germany
3yrs
|
|
|
BioNTech has already started developing a new Omicron version of its COVID-19 vaccine
3yrs
|
|
|
BioNtech says it needs 2 weeks to determine vaccine’s effectiveness against Omicron
3yrs
|
|
|
|
Vaccine makers move quickly against new omicron Covid variant, testing already under way
3yrs
|
|
|
|
COVID-19: New vaccines 'ready in 100 days' if Omicron variant is resistant to current jabs, Pfi...
3yrs
|
|
|
BioNTech says it could tweak Covid vaccine in 100 days if needed
3yrs
|
|
|
|
covid: Pfizer says Covid shot 100% effective in adolescents after 4 months
US
3yrs
|
|
|
|
Pfizer, BioNTech and Moderna are making more than $1,000 every second
3yrs
|
|
|
|
BionTech with over three billion euros net profit
3yrs
|
|
|
|
BionTech with over three billion euros net profit
3yrs
|
|
|
|
BioNTech shares nosedive on news of whistleblower report & Covid pills
US
Germany
3yrs
|
|
|
Last horde in US taken for coronavaccin children from 5 years
US
3yrs
|
|
|
|
BioNTech founders: COVID is going to become more manageable
Germany
3yrs
|
|
|
|
Native vaccination: US emergency approval for BIONTECH
US
3yrs
|
|
|
|
Africa looks to kick-start COVID vaccine production
3yrs
|
|
|
|
BioNTech to work with Senegal, Rwanda to make mRNA vaccines
Germany
Rwanda
Senegal
3yrs
|
|
|
|
Pfizer, BioNTech say COVID-19 booster shot showed high efficacy in large study
Germany
3yrs
|
|
|
|
'US FDA to allow mixing and matching of Covid-19 boosters'
US
3yrs
|
|
|
|
BIONTECH / PFIZER requested EU approval for children
US
Germany
3yrs
|
|
|
BioNTech begins Phase 2 trial of mRNA-based vaccine against cancer
Germany
3yrs
|
|
|
|
BioNTech begins Phase 2 trial of mRNA-based vaccine against cancer
Germany
3yrs
|
|
|
Pfizer and Biontech submitted an application for the use of vaccines in children from the age o...
US
3yrs
|
|
|
|
Pfizer asks US regulators to OK vaccines for kids ages 5 to 11
US
3yrs
|
|
|
|
New Covid-19 vaccines will be necessary by mid-2022 to combat ‘next generation’ of virus strain...
3yrs
|
|
|
|
New Covid-19 vaccines will be necessary by mid-2022 to combat ‘next generation’ of virus strain...
3yrs
|
|
|
|
New Covid-19 vaccines will be necessary by mid-2022 to combat ‘next generation’ of virus strain...
3yrs
|
|
|
|
COVID-19 here to stay for couple more years: BioNTech’s Türeci
3yrs
|
|
|
|
COVID-19 here to stay for couple more years: BioNTech’s Türeci
3yrs
|
|
|
|
COVID-19 here to stay for couple more years: BioNTech’s Türeci
3yrs
|
|
|
|
Biden: another 500 million coronavaccins for other countries
US
3yrs
|
|
|
|
Pfizer says data shows Covid-19 jab safe for children aged 5-11
3yrs
|
|
|
|
Pfizer says COVID vaccine safe for children 5 to 11 years old
3yrs
|
|
|
|
Pfizer-BioNTech say COVID-19 vaccine induced strong immune response in kids aged 5-11
US
3yrs
|
|
|
|
Coronavirus: BioNTech says vaccine safe for kids 5 to 11
US
3yrs
|
|
|
|
BIONTECH will soon want to provide data on child vaccine
3yrs
|
|
|
|
BioNTech ‘preparing production’ of Covid-19 vaccine for children under 12, which may be approve...
Germany
3yrs
|
|
|
Pfizer and BioNTech will soon seek clearance for vaccine use in children 5 and older.
3yrs
|
|
|
|
Is Africa ready to produce a malaria vaccine?
3yrs
|
|
|
|
Pfizer and BioNTech will soon seek clearance for vaccine use in children 5 years and over.
3yrs
|
|
|
|
BioNTech to seek global approval to use its COVID-19 vaccine in 5-11 year olds: report
3yrs
|
|
|
|
Scientists’ egos are key barrier to progress, says Covid vaccine pioneer
3yrs
|
|
|
|
BIONTECH requests approval for children's vaccine
3yrs
|
|
|
|
BIONTECH also wants coronavaccin for children from 5 years old
Germany
3yrs
|
|
|
mRNA cancer therapy now in human trials after shrinking mouse tumours
3yrs
|
|
|
|
Brazil's Eurofarma to make Pfizer COVID-19 shots for Latin America
US
Brazil
3yrs
|
|
|
|
Pfizer vaccine is fully approved in America
US
3yrs
|
|
|
Third dose against Corona: America plans refreshing vaccinations
US
3yrs
|
|
|
|
Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market
3yrs
|
|
|
|
BioNTech says it has shipped 1 billion COVID-19 vaccines so far — and twice that still to come
Germany
3yrs
|
|
|
|
BioNTech says it has shipped 1 billion COVID-19 vaccines so far — and twice that still to come
Germany
3yrs
|
|
|
Vaccine maker BioNTech sees profits soar in second quarter
Germany
3yrs
|
|
|
|
Pfizer estimates 2021 COVID-19 jab sales to be $33.5B
US
Germany
3yrs
|
|
|
Vaccine maker BioNTech to use mRNA tech to target malaria
3yrs
|
|
|
|
Vaccine maker BioNTech to use mRNA tech to target malaria
3yrs
|
|
|
|
BioNTech wants to 'eradicate' malaria with mRNA vaccine
Germany
3yrs
|
|
|
|
BioNTech aims to use mRNA tech in malaria vaccine
3yrs
|
|
|
|
South Africa’s Biovac Institute strikes deal with BioNTech and Pfizer to produce 100 million Co...
South Africa
3yrs
|
|